Tel Aviv University

Two separate deals hit the wires on Tuesday. One is PharmAla Biotech's (OTC:MDXXF) with Numinus Wellness (OTC:NUMIF) for a group therapy model with MDMA, the other is Optimi Health's (OTCQX:OPTHF) with Tel Aviv University for MDMA’s potential effects on addiction treatment. PharmAla Signs...

This article was originally published on Cannabis.net and appears here with permission. Israel has been long dominating the cannabis industry in terms of breakthrough research and developing innovative medicinal products to treat the sick. They are light years ahead compared to other ...